참고문헌
- Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-735. https://doi.org/10.1136/thx.2008.108027
- Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200. https://doi.org/10.1056/NEJM199810223391703
- James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit C are Med 2005;171:109-114. https://doi.org/10.1164/rccm.200402-230OC
- Thomsen M, Nordestgaard BG, Vestbo J, Lange P. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med 2013;1:543-550. https://doi.org/10.1016/S2213-2600(13)70137-1
- Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999;14:892-896. https://doi.org/10.1034/j.1399-3003.1999.14d27.x
- Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014;69:805-810. https://doi.org/10.1136/thoraxjnl-2013-204815
- Covar RA, Spahn JD, Murphy JR, Szefler SJ; Childhood Asthma Management Program Research Group. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 2004;170:234-241. https://doi.org/10.1164/rccm.200308-1174OC
- Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-1117. https://doi.org/10.1056/NEJM198810273191702
- Lee HY, Kang JY, Yoon HK, et al. Clinical characteristics of asthma combined with COPD feature. Yonsei Med J 2014;55:980-986. https://doi.org/10.3349/ymj.2014.55.4.980
- Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest 2007;132:1882-1889. https://doi.org/10.1378/chest.07-0713
- Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013;187:42-48. https://doi.org/10.1164/rccm.201205-0788OC
- Jamieson DB, Matsui EC, Belli A, et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188:187-192. https://doi.org/10.1164/rccm.201211-2103OC
- Moerloose KB, Pauwels RA, Joos GF. Short-term cigarette smoke exposure enhances allergic airway inflammation in mice. Am J Respir Crit Care Med 2005;172:168-172. https://doi.org/10.1164/rccm.200409-1174OC
- Iwamoto H, Gao J, Koskela J, et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J 2014;43:421-429. https://doi.org/10.1183/09031936.00024313
- Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis 2012;7:283-289.
- Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127. https://doi.org/10.1186/1465-9921-12-127
- Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297-304. https://doi.org/10.1378/chest.13-0622
- Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014;11:163-170. https://doi.org/10.3109/15412555.2013.831061
- Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD 2011;8:400-407. https://doi.org/10.3109/15412555.2011.611200
- Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31:742-750. https://doi.org/10.1183/09031936.00129607
- Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011;365:1184-1192. https://doi.org/10.1056/NEJMoa1105482
- Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease: The Lung Health Study Research Group. Am J Respir Crit Care Med 1996;153(6 Pt 1):1802-1811. https://doi.org/10.1164/ajrccm.153.6.8665038
- Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-1726. https://doi.org/10.1056/NEJMoa1008770
- Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198-1207. https://doi.org/10.1056/NEJMoa1208606
- Iwamoto H, Yokoyama A, Shiota N, et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J 2008;31:1379-1380. https://doi.org/10.1183/09031936.00014108
- Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177:148-155. https://doi.org/10.1164/rccm.200707-1134OC
- Brusselle GG, Vanderstichele C, Jordens P, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 2013;68:322-329. https://doi.org/10.1136/thoraxjnl-2012-202698
- Price D, Popov TA, Bjermer L, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013;131:763-771. https://doi.org/10.1016/j.jaci.2012.12.673
- Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178:332-338. https://doi.org/10.1164/rccm.200712-1869OC
- Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-1178. https://doi.org/10.1016/S0140-6736(09)61298-8
- Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-698. https://doi.org/10.1056/NEJMoa1104623
- Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2014;2:361-368. https://doi.org/10.1016/S2213-2600(14)70019-0
- Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331-337.
피인용 문헌
- The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/4503267
- Chronic bronchitis is an independently associated factor for more symptom and high-risk groups vol.11, pp.None, 2016, https://doi.org/10.2147/copd.s105516
- High prevalence of chronic obstructive pulmonary disease in Korea vol.31, pp.4, 2015, https://doi.org/10.3904/kjim.2016.196
- Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease vol.12, pp.None, 2015, https://doi.org/10.2147/copd.s120445
- Trend of cost and utilization of COPD medication in Korea vol.12, pp.None, 2017, https://doi.org/10.2147/copd.s121687
- Peripheral leukocyte microRNAs as novel biomarkers for COPD vol.12, pp.None, 2017, https://doi.org/10.2147/copd.s130416
- Heterogeneity of asthma–COPD overlap syndrome vol.12, pp.None, 2015, https://doi.org/10.2147/copd.s130943
- Characterization of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Qualitative Analysis vol.14, pp.3, 2015, https://doi.org/10.1080/15412555.2017.1318841
- Heterogeneity of asthma and COPD overlap vol.13, pp.None, 2015, https://doi.org/10.2147/copd.s152916
- Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey vol.10, pp.3, 2015, https://doi.org/10.4168/aair.2018.10.3.225
- Is ACOS an independent nosology? Clinical signs and diagnosis of ACOS vol.28, pp.5, 2018, https://doi.org/10.18093/0869-0189-2018-28-5-519-529
- Longitudinal analysis to better characterize Asthma‐COPD overlap syndrome: Findings from an adult asthma cohort in Korea (COREA) vol.49, pp.5, 2015, https://doi.org/10.1111/cea.13339
- A comparison of diagnostic consistency for asthma-chronic obstructive pulmonary disease overlap and clinical characteristics study vol.19, pp.1, 2015, https://doi.org/10.1186/s12890-019-1024-2
- The Status and Influencing Factors of Respiratory System Diseases in Korean Farmers with Disease vol.31, pp.4, 2015, https://doi.org/10.7856/kjcls.2020.31.4.779